Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
drug class effect
Description:
A drug class effect is a therapeutic or adverse effect considered shared among medicines belonging to the same pharmacological class.
Related topics:
Blood Pressure and Hypertension Studies (12%),
Diabetes Treatment and Management (11%),
Inflammatory mediators and NSAID effects (7%)
OpenAlex ID:
keywords/drug-class-effect
Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis
2010
·
Alastair JS Webb
, Urs Fischer
, et al.
·
The Lancet
·
778
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
2009
·
M. Briel
, I. Ferreira-Gonzalez
, et al.
·
BMJ
·
536
PDF
Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of Randomized Trials
2006
·
Jingjing Zhang
, Eric L. Ding
, et al.
·
JAMA
·
387
Systematic review: hypomagnesaemia induced by proton pump inhibition
2012
·
M. W. Hess
, J. G. J. Hoenderop
, et al.
·
Alimentary Pharmacology & Therapeutics
·
253
Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials
2016
·
Huilin Tang
, Xi Zhang
, et al.
·
Diabetologia
·
172
PDF
Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial Infarction: A Class Effect?
2004
·
Louise Pilote
, Michal Abrahamowicz
, et al.
·
Annals of Internal Medicine
·
141
Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis
2018
·
Jacqueline M McMillan
, Bria S Mele
, et al.
·
BMJ Open Diabetes Research & Care
·
90
PDF
Does Blood Pressure Variability Modulate Cardiovascular Risk?
2011
·
Peter M. Rothwell
·
Current Hypertension Reports
·
78
Drug Hepatotoxicity
2006
·
Rahul A. Nathwani
, Neil Kaplowitz
·
Clinics in Liver Disease
·
65
Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug class
2012
·
Donald L. Bliwise
, Lynn Marie Trotti
, et al.
·
Movement Disorders
·
57
Mechanisms linking empagliflozin to cardiovascular and renal protection
2017
·
Pasquale Perrone-Filardi
, Angelo Avogaro
, et al.
·
International Journal of Cardiology
·
55
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management
2017
·
Niki Katsiki
, Dimitri P. Mikhailidis
, et al.
·
Current Pharmaceutical Design
·
52
PDF
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging
2011
·
for the Italian Longitudinal Study on Aging Working Group
, Vincenzo Solfrizzi
, et al.
·
AGE
·
50
PDF
Fentanyl Delays the Platelet Inhibition Effects of Oral Ticagrelor: Full Report of the PACIFY Randomized Clinical Trial
2018
·
Khalil Ibrahim
, Rohan Shah
, et al.
·
Thrombosis and Haemostasis
·
49
PDF
Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan
2020
·
Kuan-Chan Chen
, Chi-Hsiang Chung
, et al.
·
Journal of Clinical Medicine
·
36
PDF
Psoriasiform Reactions to Anti–Tumor Necrosis Factor α Therapy
2013
·
Khang Nguyen
, Ruth Ann Vleugels
, et al.
·
JCR Journal of Clinical Rheumatology
·
36
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
2020
·
Masato Furuhashi
, Ichiro Sakuma
, et al.
·
Cardiovascular Diabetology
·
34
PDF
Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk
2018
·
Motoaki Sano
·
Journal of Cardiology
·
34
Allergic interstitial nephritis possibly related to sunitinib use
2007
·
Anand Khurana
·
The American Journal of Geriatric Pharmacotherapy
·
34
Dolutegravir neuropsychiatric adverse events: specific drug effect or class effect
2018
·
Jean Cyr Yombi
·
Aids Reviews
·
33
Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway
2017
·
Takayuki Kimura
, Mai Uesugi
, et al.
·
Toxicology and Applied Pharmacology
·
31
Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials
2016
·
Sevil Yasar
, Mattan Schuchman
, et al.
·
Current Hypertension Reports
·
31
PDF
Influence of Study Design Variables on Clinical Pathology Data
2016
·
Adam Aulbach
, Anne Provencher
, et al.
·
Toxicologic Pathology
·
30
PDF
Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments
2011
·
M. O. Gore
, D. K. McGuire
·
European Heart Journal
·
27
Thromboembolic Cardiovascular Risk Among Arthritis Patients Using Cyclooxygenase-2-Selective Inhibitor or Nonselective Cyclooxygenase Inhibitor Nonsteroidal Anti-inflammatory Drugs
2007
·
William M Spalding
, Mathew J Reeves
, et al.
·
American Journal of Therapeutics
·
27
Show more works
View as search
Works count:
110
Citation count:
3,565
Year
Topic
Type